TITLE:
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

CONDITION:
Breast Cancer

INTERVENTION:
zoledronic acid

SUMMARY:

      Patients with bone metastases or bone lesions caused by breast cancer, multiple myeloma or
      prostate cancer will be treated with IV Zometa in a 15 minute infusion. Pain will be
      evaluated, as well as time in chair, quality of life and safety of Zometa.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

          -  Signed informed consent

          -  Greater than 18 years of age

          -  Proof of breast cancer, multiple myeloma or prostate cancer

          -  Diagnosis of at least one cancer-related bone lesion

          -  If patient is of child-bearing potential, negative pregnancy test and on a medically
             recognized form of contraception

          -  ECOG performance status of 0,1 or 2

          -  Ability to read, understand and write English or Spanish language

          -  Normal renal function

          -  Corrected serum calcium equal to or greater than 8mg/dl Exclusion Criteria

          -  clinically symptomatic brain metastases

          -  hypersensitivity to Zometa or other bisphosphonates

          -  pregnant or lactating
      
